This review and meta-analysis (2021) explores the current evidence on using ketamine to treat migraines and other primary headache disorders. The authors found inconclusive evidence across five randomised-controlled trials (RCTs) which was attributed to the high risk of bias, small sample sizes, heterogeneity of the outcomes reported, and heterogeneity of the comparison groups.
- Published
- Journal
- Journal of Dental Anesthesia and Pain Medicine
- Authors
- Chah, N., Jones, M., Milord, S., Al-Eryani, K., Enciso, R.